Food and Drug Administration Commissioner Marty Makary said his agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost of their medicines between the US and other ...

FDA Commissioner Marty Makary said during an interview with Bloomberg Television that his agency may expedite reviews of ...

WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to ... Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months.

FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...

FDA to offer faster drug reviews to companies promoting 'national priorities' SEX ABUSE IN THE CATHOLIC CHURCH. RIGHT NOW WE TURN TO FIVE ON YOUR HEALTH TONIGHT, A MAJOR CHANGE FOR MILLIONS OF ...

U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting ''the health interests of Americans,'' under a new initiative announced Tuesday.

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health. The new program announced ...

FDA’s long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases. Regular drug reviews take about 10 months.

FDA to offer faster drug reviews to companies promoting ‘national priorities’ The FDA already has a variety of programs designed to speed up drug reviews, but they all have fairly strict ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health.

Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA’s long-standing accelerated approval program generally issues ...